Avantor Reports Third Quarter 2026 Results

10/28/2026
Impact: 72
Healthcare

Avantor reported third-quarter 2026 net sales of $1,698.3 million, up 4.6% year over year, with diluted GAAP EPS of $0.30 and adjusted EPS of $0.22. The company said revenue and adjusted EPS exceeded expectations and highlighted its return to year-over-year growth. Avantor raised its full-year 2026 guidance for organic revenue growth, adjusted EPS and free cash flow. At September 30, 2026, it had $3,699.7 million in total debt and $464.3 million in cash and cash equivalents.

AI summary, not financial advice

Share: